Pro CLB Global Limited passed all five resolutions at its 32nd Annual General Meeting held on September 30, 2026, with 99.99% of valid votes cast in favor. The meeting, conducted via video conferencing, saw the adoption of audited financial statements for FY26 and several key governance appointments.

The company’s CEO, Monil Navinchandra Vora, submitted the voting results to BSE on October 1, 2026. Out of 1,788 shareholders on the record date, 95 members participated in the voting process, representing 13.54% of the total paid-up capital. No invalid votes were recorded across any resolution.

Voting Participation and Results

The scrutinizer’s report, prepared by Rohit Bhatia & Associates, confirmed that remote e-voting commenced on September 27, 2026, and concluded on September 29, 2026. An additional 15-minute window was provided during the AGM for members who had not voted remotely. The final tally showed overwhelming support for all agenda items, with dissenting votes accounting for only 0.01% of the total valid votes polled.

Governance and Board Changes

The meeting addressed significant governance updates aligned with regulatory requirements. Satish Papnai was regularized from his role as an additional director to an Independent Director through a special resolution. This move strengthens the board's compliance framework.

Additionally, M/s. Shweta Jain & Co LLP was appointed as Statutory Auditors for a term extending until the conclusion of the 37th AGM. M/s Rohit Bhatia & Associates were appointed as Secretarial Auditors for a term of five consecutive financial years. The reappointment of Het Kalpeshkumar Shah as a Non-Executive Director retiring by rotation was also approved.

Resolution Highlights

The following ordinary and special resolutions were passed with the requisite majority:

1. Adoption of audited financial statements and reports for FY26.
2. Reappointment of Het Kalpeshkumar Shah as Non-Executive Director.
3. Appointment of M/s. Shweta Jain & Co LLP as Statutory Auditors.
4. Regularization of Satish Papnai as an Independent Director.
5. Appointment of M/s Rohit Bhatia & Associates as Secretarial Auditors.

Voting rights were reckoned on the paid-up value of shares registered in the name of members as on the cut-off date of September 23, 2026. The meeting concluded at 4:25 pm with a vote of thanks.

Pro CLB Global approved the allotment of 1,09,20,255 convertible warrants to 130 non-promoter investors on September 16, 2026. The preferential issue was priced at ₹31.96 per warrant, with an initial collection of ₹7.99 per warrant representing 25% of the total consideration.

The Board of Directors sanctioned the allotment during a meeting held on September 16, 2026, from 5:00 pm to 5:30 pm. The issuance complies with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Allotment Details

The warrants entitle holders to subscribe to one equity share per warrant upon payment of the remaining 75% of the issue price. Holders must exercise this right within 18 months from the date of allotment. Failure to exercise the warrants within this period will result in their lapse, and the amounts paid will be forfeited by the company.

Ten applicants were not allotted warrants due to non-receipt of the required 25% upfront payment. These include Chirayu Aggarwal, Geeta Sanjay Arora, and Siroya Enterprise.

Key Investors

The allotment was distributed among a broad base of retail and high-net-worth individuals, along with a few corporate entities. Mideast Healthcare Pvt Ltd received the largest single allotment of 700,000 warrants. Rajnikant Chandulal Shukla HUF was allotted 650,000 warrants, followed by Neeta Mandevia with 531,915 warrants.

What the Numbers Show

The wide dispersion of allottees, with 130 distinct recipients and no single investor holding more than 4.37% of the post-allotment stake, indicates a strategy to broaden the shareholder base rather than consolidate control. The inclusion of multiple HUFs and individual family members suggests participation from the company's existing promoter or management circle, structured as non-promoter investments.